evidence table
Probiotic Eczema Meta-Analysis Evidence Table
Structured evidence table for Probiotic Eczema Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Probiotic Eczema Meta-Analysis | 1 2 3 1 2 3 1 2 3 The prevalence of food allergy in children has increased substantially over recent decades, representing a growing public health challenge [,,]. | 1 | Bodó Diána (2026) | Prenatal and Early-Life Exposure to Microbiome-Modulating Medications and the Risk of Childhood Food Allergy: A Systematic Review and Meta-Analysis |
| Probiotic Eczema Meta-Analysis | 4 5 Antibiotic exposure during pregnancy or early life has been associated with an increased risk and earlier onset of food allergy. | 1 | Bodó Diána (2026) | Prenatal and Early-Life Exposure to Microbiome-Modulating Medications and the Risk of Childhood Food Allergy: A Systematic Review and Meta-Analysis |
| Probiotic Eczema Meta-Analysis | Several observational studies have reported associations between prenatal or postnatal acid-suppressive medication use and increased risk of food allergy []. | 1 | Bodó Diána (2026) | Prenatal and Early-Life Exposure to Microbiome-Modulating Medications and the Risk of Childhood Food Allergy: A Systematic Review and Meta-Analysis |
| Probiotic Eczema Meta-Analysis | Early immune development is critically shaped by the establishment of the gut microbiome, which plays a central role in the induction of oral tolerance to dietary antigens. | 1 | Bodó Diána (2026) | Prenatal and Early-Life Exposure to Microbiome-Modulating Medications and the Risk of Childhood Food Allergy: A Systematic Review and Meta-Analysis |
| Probiotic Eczema Meta-Analysis | However, this surge in popularity contrasts sharply with significant evidence gaps. | 1 | Sun Wenrui (2026) | Maternal probiotic supplementation and offspring health: an umbrella review with re-analysis of systematic reviews and meta-analyses |
| Probiotic Eczema Meta-Analysis | Food and Drug Administration has not approved any probiotic product as a drug or biological product for infants (0–12 months) due to insufficient evidence regarding their efficacy and safety (). | 1 | Sun Wenrui (2026) | Maternal probiotic supplementation and offspring health: an umbrella review with re-analysis of systematic reviews and meta-analyses |
| Probiotic Eczema Meta-Analysis | This discrepancy between widespread use and limited evidence raises concerns about potential risks to maternal pregnancy outcomes and infant health, including rare probiotic-associated infections in vulnerable individuals and largely theoretical effects on neonates through maternal supplementation (). | 1 | Sun Wenrui (2026) | Maternal probiotic supplementation and offspring health: an umbrella review with re-analysis of systematic reviews and meta-analyses |
| Probiotic Eczema Meta-Analysis | 1 2 3 4 5 6 7 In recent decades, the gut microbiota has gained increasing recognition for its critical role in immunity (), metabolism (), and other physiological processes. | 1 | Sun Wenrui (2026) | Maternal probiotic supplementation and offspring health: an umbrella review with re-analysis of systematic reviews and meta-analyses |
Source documents